A Science and Technology Blog
Protection conferred by BCG vaccine against novel coronavirus is an interesting study and a plausible hypothesis but has been done early in the course of an epidemic and when the…
While conventional human clinical trials of novel coronavirus vaccine will take 12-18 months to complete, the human challenge studies can speed up the process and help complete the trial by…
Moderna’s mRNA-1273 is the first vaccine for novel coronavirus (SARS-CoV-2) to enter human trials. This is a novel lipid nanoparticle-encapsulated mRNA vaccine that codes for the full-length prefusion stabilised spike…
U.S. researchers have 3D mapped the spike protein of the novel coronavirus. Unlike SARS, the spike protein of SARS-CoV-2 shows 10- to 20-fold higher affinity to bind to the human…
With the continued risk of international spread, WHO has announced that polio will remain a public health emergency for three more months. Polio was declared as public health emergency of…
Serum Institute is optimistic that its pneumococcal vaccine will be available in India by June 2020. The vaccine is yet to be approved by the DCGI. But phase-3 trial data…
WHO has prequalified Pune-based Serum Institute’s pneumococcal conjugate vaccine made of 10 serotypes that are widely prevalent and cause pneumonia in Latin America, Africa and Asia. The vaccine will cost…
Changing the route of BCG vaccine administration from intradermal to intravenous and using a higher dosage showed vast improvement in vaccine efficacy. Nine of the 10 animals that received the…
